官方微信|手機(jī)版|本站服務(wù)|買家中心|行業(yè)動態(tài)|幫助

產(chǎn)品|公司|采購|招標(biāo)

Mevastatin (美伐他?。?a href="javascript:void(0)" onclick="addCompareForDetail(this)" data-id='4323843' data-classid='2354' data-name='Mevastatin (美伐他汀)' class="comBtn" target="_self">

參考價550.00
具體成交價以合同協(xié)議為準(zhǔn)
  • 公司名稱杭州昊鑫生物科技股份有限公司
  • 品       牌MCE
  • 型       號HY-17408
  • 所  在  地杭州市
  • 廠商性質(zhì)代理商
  • 更新時間2024/6/24 14:27:39
  • 訪問次數(shù)114
產(chǎn)品標(biāo)簽:

美伐他汀

規(guī)格
50mg550.00元10000 支可售
在線詢價 收藏產(chǎn)品 查看電話 同類產(chǎn)品

聯(lián)系我們時請說明是 制藥網(wǎng) 上看到的信息,謝謝!

杭州昊鑫生物科技股份有限公司成立于2009年初,是一家面向生命科學(xué)領(lǐng)域,從事科研機(jī)構(gòu)、高校、院所及生產(chǎn)企業(yè)所需科研試劑、耗材,儀器銷售和服務(wù)面向全國。

產(chǎn)品和服務(wù)涵蓋生命科學(xué)研究技術(shù)的諸多方面,提供覆蓋分子生物學(xué)、細(xì)胞生物學(xué)、植物學(xué)、生物化學(xué)、蛋白組學(xué)、免疫學(xué)等領(lǐng)域的實(shí)驗(yàn)產(chǎn)品以及生物技術(shù)服務(wù)等。目前一級代理品牌有:MCE(Medchemexpress)、Biochannel、AATbio、invivogen、Abnova、Atlas、Origene、Biovision、云克?。–loud-clone)、艾德萊(Aidlab)、Cayman、Jackson、Epigentek、Prospec、Sciencell、icellbioscience(賽百慷)、hkABCbio、chondrex、Mybiosource、Abbexa、Innovrsrch、HPI、Hitobiotec、Greerlabs,Ostex,4ADI,LDN等。

經(jīng)營理念:以誠信為本,保證產(chǎn)品質(zhì)量求生存,創(chuàng)造企業(yè)核心競爭力求發(fā)展 , 堅持用戶至上、服務(wù)至上的原則 。


胎牛血清、MCE抑制劑激動劑、RNA提取試劑盒、ELISA試劑盒、重組蛋白
CAS號 73573-88-3 產(chǎn)地 國產(chǎn)
規(guī)格 50mg 級別 化工級
證書 ISO系列證書
Mevastatin (Compactin) 是屬于他汀類的 HMG-CoA 還原酶抑制劑。Mevastatin 是一種降脂藥,可誘導(dǎo)細(xì)胞凋亡,將癌細(xì)胞阻滯在 G0/G1 期。Mevastatin 還可以增加內(nèi)皮型一氧化氮合酶 (eNOS) 的 mRNA 和蛋白質(zhì)水平。Mevastatin 具有抗腫瘤活性,并可用于心血管疾病的研究。
Mevastatin (美伐他?。?/span> 產(chǎn)品信息

Mevastatin  (Synonyms: 美伐他汀; Compactin; ML236B)

Mevastatin (Compactin) 是屬于他汀類的 HMG-CoA 還原酶抑制劑。Mevastatin 是一種降脂藥,可誘導(dǎo)細(xì)胞凋亡,將癌細(xì)胞阻滯在 G0/G1 期。Mevastatin 還可以增加內(nèi)皮型一氧化氮合酶 (eNOS) 的 mRNA 和蛋白質(zhì)水平。Mevastatin 具有抗腫瘤活性,并可用于心血管疾病的研究。

生物活性

Mevastatin (Compactin) is a first HMG-CoA reductase inhibitor that belongs to the statins class. Mevastatin is a lipid-lowering agent, and induces apoptosis, arrests cancer cells in G0/G1 phase. Mevastatin also increases endothelial nitric oxide synthase (eNOS) mRNA and protein levels. Mevastatin has antitumor activity and has the potential for cardiovascular diseases treatment[1][2][3].


IC50 & Target

HMG-CoA reductase[1][2]
Apoptosis[1]


體外研究(In Vitro)

Mevastatin (0-128 µM; 5 days; Caco-2 cells) treatment causes a dose-dependent decrease in cell number[1].
Mevastatin (32-128 µM; 24-72 hours; Caco-2 cells) treatment causes an early G0/G1 phase and a late G2/M phase cell cyclr arrest[1].
Mevastatin (32-128 µM; 72 hours; Caco-2 cells) treatment causes a down-regulation of cyclin-dependent kinases (cdk) 4 and cdk 6 as well as cyclin D1, while cdk 2 and cyclin E protein levels remained unchanged. Cell cycle inhibitors p21 and p27 are significantly upregulated by Mevastatin[1].
Mevastatin (16-256 µM; Caco-2 cells) treatment induces apoptosis in a dose-dependent manner[1].
Treatment of Neuro2a cells with mevastatin for 24 hours induced neurite outgrowth associated with up-regulation of the neuronal marker protein NeuN. Mevastatin triggers phosphorylation of the key kinases epidermal growth factor receptor (EGFR), ERK1/2, and Akt/protein kinase B. Inhibition of EGFR, PI3K, and the mitogen-activated protein kinase cascade blocks Mevastatin-induced neurite outgrowth[4].

Cell Viability Assay[2]

Cell Line:Caco-2 cells
Concentration:0 µM, 8 µM, 16 µM, 32 µM, 64 µM, 128 µM
Incubation Time:5 days
Result:Caused a dose-dependent decrease in cell number.


體內(nèi)研究(In Vivo)

Mevastatin (2-20 mg/kg; delivered via ALZET miniosmotic pumps; daily; for 7, 14, or 28 days; wild-type 129-SV/eVTAcBr male mice and eNOS-deficient male mice) treatment increases levels of endothelial nitric oxide synthase (eNOS) mRNA and protein, reduces infarct size, and improves neurological deficits in a dose- and time-dependent manner[2].
The topical infusion of Mevastatin (2.5 pmol/hr) increases bone mass (MRL/MpJ mouse) of isografted bone by increasing bone turnover and, at least in part, by promoting the expression of bone morphogenetic protein-2 (BMP-2) mRNA and receptor activator of NF-κB ligand (RANKL) mRNA[3].

Animal Model:Wild-type 129-SV/eVTAcBr male mice and eNOS-deficient male mice (18-22 g) with the filament model[2]
Dosage:2 mg/kg or 20 mg/kg
Administration:Delivered via 7- or 14-day ALZET miniosmotic pumps implanted subcutaneously; daily; for 7, 14, or 28 days
Result:Increased levels of endothelial nitric oxide synthase (eNOS) mRNA and protein, reduced infarct size, and improved neurological deficits in a dose- and time-dependent manner.


分子量:390.51


性狀:Solid


Formula:C23H34O5


CAS 號:73573-88-3


中文名稱:洛伐ta汀EP雜質(zhì)A


來源:Penicillium citrinum


運(yùn)輸條件

Room temperature in continental US; may vary elsewhere.


儲存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)



溶解性數(shù)據(jù)


In Vitro: 

DMSO : 250 mg/mL (640.19 mM; Need ultrasonic)

配制儲備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM2.5608 mL12.8038 mL25.6075 mL
5 mM0.5122 mL2.5608 mL5.1215 mL
10 mM0.2561 mL1.2804 mL2.5608 mL
*

請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲存時,請在 6 個月內(nèi)使用,-20°C 儲存時,請在 1 個月內(nèi)使用。

In Vivo:

以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶

  • 1.


    請依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (6.40 mM); Clear solution


  • 2.


    請依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (6.40 mM); Clear solution


  • 3.


    請依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (6.40 mM); Clear solution


參考文獻(xiàn)

[1]. W?chtersh?user A, et al. HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis. 2001 Jul;22(7):1061-7.  [Content Brief]

[2]. Amin-Hanjani S, Stagliano NE, Yamada M, et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001 Apr;32(4):980-6.  [Content Brief]

[3]. Sugazaki M, Hirotani H, Echigo S, et al. Effects of mevastatin on grafted bone in MRL/MpJ mice. Connect Tissue Res. 2010 Apr;51(2):105-12. [Content Brief]

[4]. Evangelopoulos ME, Weis J, Krüttgen A. Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR. J Neurosci Res. 2009 Jul;87(9):2138-44.  [Content Brief]

注:產(chǎn)品僅用于科研

同類產(chǎn)品推薦
在找 Mevastatin (美伐他?。?產(chǎn)品的人還在看

提示

×

*您想獲取產(chǎn)品的資料:

以上可多選,勾選其他,可自行輸入要求

個人信息: